Antiobestic agents and health foods

Details Antiobestic agents and health foods Antiobestic agents and health foods

2007-04-03

2007-04-03

Lewis, Patrick (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C424S078010, C424S078100, C424S078160, C514S909000, C514S911000

Reexamination Certificate

active

10432877

ABSTRACT:
Antiobestic agents and health foods containing as the active ingredient substances having an effect of adsorbing bile acid in the digestive tract, an effect of inhibiting intestinal circulation or an effect of inhibiting the absorption of exogenous lipids typified by pharmaceutically acceptable anion exchange resins. In particular, antiobestic agents and health foods characterized by lowering body weight and/or visceral fat content without reducing food intake.

REFERENCES:
patent: 4765994 (1988-08-01), Holmgren
patent: 5286481 (1994-02-01), Weisenfeld
patent: 5380522 (1995-01-01), Day
patent: 5447726 (1995-09-01), Nomura
patent: 5980881 (1999-11-01), Mitsuka et al.
patent: 5-186356 (1993-07-01), None
patent: 11-147828 (1999-06-01), None
patent: 92/08469 (1992-05-01), None
patent: 97/36927 (1997-10-01), None
Katsuhiko Tokunaga, “Himan wo Gappei shita Kou-Ketsuatsusou no Chiryou”, Prog. Med., vol. 20, No. 10, Oct. 20, 2000, pp. 1979 to 1982 (hereinafter “the Tokunaga article”), (together with an English translation of its relevant portions in a Rule 131 Declaration).
A. Must et al., “The Disease Burden Associated with Overweight and Obesity”, JAMA, vol. 282, No. 16, pp. 1523-1529, Oct. 27, 1999.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), pp. 1-27, May 2001.
Obesity in the United states Workforce, Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000, pp. 1-12, Dec. 2004.
Jean-Pierre Despres et al., “Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia”, The New England Journal of Medicine, vol. 353, No. 20, pp. 2121-2134, Nov. 17, 2005.
S. J. Nicholls et al., “Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits ofAtorvastatinorPravastatinin Patients with Coronary Artery Disease (from the REVERSAL Study)”, Am. J. Cardiol., vol. 97, pp. 1553-1557, 2006.
D. B. Hunninghake et al., “Comparative Effects of Simvastatin and Atorvastatin in Hypercholesterolemic Patients with Characteristics of Metabolic Syndrome”, Clinical Therapeutics, vol. 25, No. 6, pp. 1670-1686, 2003.

Affiliated with

Also associated with

Rating

Antiobestic agents and health foods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiobestic agents and health foods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiobestic agents and health foods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3743776